Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Albany Molecular Research Inc (NASDAQ:AMRI)

15.05
Delayed Data
As of Apr 29
 -0.37 / -2.40%
Today’s Change
13.71
Today|||52-Week Range
22.48
-24.18%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues226.7M246.6M276.6M402.4M
 
 
 
 
 
Cost of Goods Sold153.9M158.8M184.4M268.5M
 
 
 
 
 
Depreciation And Amortization17.3M15.9M18.4M27.0M
 
 
 
 
 
 
Operating ExpensesGross Income55.5M71.9M73.8M106.8M
 
 
 
 
 
General Expenses41.8M40.8M47.6M81.2M
 
 
 
 
 
Research And Development906.0K414.0K1.0M5.5M
 
 
 
 
 
Total Operating Expenses213.0M215.4M250.4M376.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income13.7M31.1M26.2M25.6M
 
 
 
 
 
Extraordinary Charge-12.3M-11.0M-21.7M-12.0M
 
 
 
 
 
Interest Expense On Debt463.0K1.3M11.0M19.4M
 
 
 
 
 
Other Expenses-837.0K772.0K1.1M2.2M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income119.0K19.7M-5.5M-3.5M
 
 
 
 
 
Income Taxes-3.9M-7.0M-2.2M-1.2M
 
 
 
 
 
Net Income-3.8M12.7M-3.3M-2.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS30.3M30.9M31.5M33.2M
 
 
 
 
 
Shares To Calculate EPS Diluted30.3M31.8M31.5M33.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.12$0.40-$0.10-$0.07
 
 
 
 
 
EPS Diluted-$0.12$0.40-$0.10-$0.07